Cancer Research UK Brain Tumour Conference 2024

Cancer Research UK Brain Tumour Conference 2024

We are pleased to announce the Cancer Research UK Brain Tumour Conference is returning for an in-person event in September 2024.

By Cancer Research UK

Date and time

Tue, 24 Sep 2024 09:00 - Thu, 26 Sep 2024 18:00 GMT+1

Location

Park Plaza London Riverbank

18 Albert Embankment London SE1 7TJ United Kingdom

Refund Policy

Contact the organiser to request a refund.
Eventbrite's fee is nonrefundable.

About this event

  • 2 days 9 hours

World-leading researchers will present their latest research alongside presentations from early-career researchers selected from submitted abstracts. The programme will include panel discussions, poster discussions, and prizes that will encourage further interactions.

We will explore emerging ideas, novel tools and recent developments in brain tumour research – from the transformative potential of new technologies and machine learning to improve our fundamental understanding of the unique environment of brain tumours to rapidly evolving advances in cancer therapy.

Across three days, we'll bring together a diverse community of discovery research and translational and clinical perspectives on brain tumours.

Major themes include:

• 3D genomes

• Spatial sequencing

• Artificial intelligence and machine learning

• Brain tumour metabolism

• Model organisms and the tumour microenvironment

• Brain tumour metastasis

• Clinical trials

The full programme will be available shortly.

For more programme information, please visit our website.

Abstracts

We're giving attendees the opportunity to showcase their work and present a poster as part of the conference programme. A limited number of lightning talks will be selected from the submitted abstracts, with priority for PhD students and postdocs. Abstracts should be 500 words max.

Deadline for abstracts is 24 May 2024.

Applicants will be notified of acceptance from 22 July 2024. The presenting author of the abstract must register for the event.

Poster viewing will take place throughout the conference.

Submit your abstract here

Photography and filming

Photography and filming will be taking place at this event for use in future CRUK science communications including, but not limited to, newsletters, publications, marketing emails, webpages, and social media. (Individuals will not be identified by name or affiliation when using any images).

If you do not wish to be featured, please speak to a member of Cancer Research UK at the registration desk or email researchevents@cancer.org.uk

Contact us

If you need more information about the event please contact us: researchevents@cancer.org.uk

COVID-19 guidance

The health and safety of our attendees and those you work with remains our highest priority. We will continue to closely monitor developments relating to COVID-19 and review guidance from government bodies. Further information and advice will be emailed to registered attendees ahead of the event.

Inclusive research and innovation events

We've prioritised embedding Equality, Diversity and Inclusion (EDI) across all our research activities to help foster environments that support innovation and creativity. Our research events are designed to showcase cutting-edge science, bring together an international scientific community and facilitate collaborations.

We want to provide welcoming and inclusive research events where we inspire, inform and engage a range of researchers and promote a positive research culture for everyone. To support this, we've developed a code of conduct to set out our expectations for everyone involved in our research events.

Code of Conduct


Organised by

Cancer Research UK (CRUK) is the largest independent funder of cancer research in Europe and the world’s leading charity dedicated to cancer research. Our vision is to bring forward the day when all cancers are cured.

We fund high-calibre, innovative research that we believe has the potential to provide the greatest benefit to the public and cancer patients. We work in partnership to achieve the greatest impact. We invest around £400m every year through funding schemes, initiatives and a UK-wide network of research infrastructure across basic, translational, clinical and population research.

Early bird discount
From £239.06